This story was first published in digitalhealth.net

Patients are set to benefit from cutting edge medical advances and treatments as part of a £260 million investment to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.
Up to £200 million will be invested to enable research to better access NHS data through Trusted Research Environments and digital clinical trial services. This will make crucial data more securely and quickly available for research, while offering the highest levels of privacy.
It will also ensure that the NHS will be able to deliver new life-saving treatments to patients faster, and will support more diverse and inclusive clinical research to tackle health inequalities and improve patient care.
The £200 million funding into the healthcare system will deliver on government commitments set out in the Life Sciences Vision, to harness NHS data to drive health research and innovation, building on pioneering work carried out during the pandemic to develop diagnostics and treatment for Covid-19. This includes the RECOVERY trial which made use of NHS data through NHS DigiTrials and led to the discovery of Dexamethasone, the world’s first proven treatment for Covid-19, in just 100 days, which has saved at least a million lives across the world.
A further £60 million will support commercial-scale manufacturing investments by companies at the leading-edge of innovation, from cell and gene therapies and earlier and better diagnostic technologies, to medical devices.
Health and Social Care Secretary Sajid Javid said: “NHS data is making the whole world safer and healthier and has been vital in saving thousands of lives during the Covid-19 pandemic. This funding will ensure the UK can continue to help researchers access NHS data securely so patients can benefit from more innovative treatments faster. I’m absolutely committed to boosting the UK’s position as a world-leading research centre, transforming our health service and ensuring the NHS continues to deliver excellent care for patients.”
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly